Buoyant Capital bought 2,86,535 shares of Granules India Limited for ₹25.00 Cr at ₹872.50 apiece in a block deal.
A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.
Mumbai-based founded in 2016. Runs cycle-aware multi-cap strategies. Led by Jigar Mistry (ex-Director Research at HSBC), Sachin Khivasara, and Viral Berawala.
